1.CDU diagnosed PAD limbs had lower ABI values compared to the non-PAD limbs, and the difference was statistically significant.
彩超诊断的PAD组与非PAD组比较,PAD组ABI明显低于非PAD组,两者差异具有统计学意义。
2.It escribes the fundamental principles, graph, and written form of PAD; and it introduces the method for describing the data structure; and finally, it shows the standard graph of PAD and its applications in BASIC, FORTRAN, COBOL, PL/Ⅰ, dBASE Ⅱ, and other high-level language programming.
阐述了PAD的基本原理、图式及其写法,PAD描述数据结构的方法,标准图式和应用PAD对诸如BASIC、PASCAL、FORTRAN、COBOL、PL/Ⅰ以及dBASEⅡ高级语言进行程序设计的力法。
3.Using the PAD criterion by CDU, the sensitivity of PVL was 81.25%, the specificity was 95.83%, the positive predictive value was 92. 86%, the negative predictive value was 88.46% and the global accuracy was 90%.
彩超和PVL均诊断为PAD的肢体占32.5%。 以彩超诊断PAD为标准,PVL诊断PAD的敏感性为81.25%,特异性为95.83%,阳性预测值为92.86%,阴性预测值为88.46%,诊断符合率为90%;
4.Conclusions: Using CDU as diagnostic standard for PAD, PVL was shown to be an efficient diagnostic method for PAD.
结论:以彩超PAD的诊断标准为依据,PVL有较高的诊断价值。
5.The amplified gene was cloned into the pENTR11 vector. With the pENTR11-SLC plasmid and the backbone plasmid pAd/CMV/V5-DEST, the homologous recombination reaction took place in vitro. The reaction mixture was transferred into TOP10 E.
方法采用PCR技术从含有SLC基因的质粒上扩增出SLC基因,将PCR产物酶切后连接至pENTR11载体上,再通过pENTR11与腺病毒骨架载体pAd/CMV/V5-DEST之间的同源重组作用将SLC基因片段重组至pAd/CMV/V5-DEST上,最后经293细胞的包装扩增后得到携带SLC基因的重组腺病毒。
6.The results revealed that the hepatic reserve function of the rats with DSCS and PAD had significant difference as compared with the control (P0. 05).
结果表明：术后第1周DSCS、PAD和MCS与肝硬变组比较无显著性差异（P＞0．05）； 而术后第3和5周，DSCS和PAD组与肝硬变组比较有显著性差异（P＜0．05），MCS组与肝硬变组比较无显著性差异（P＞0．05）。
7.Mass of >0.25 mm water-stable aggregate is 23.8%-45.4%. Percentage of aggregate destruction(PAD) ranges from 52.4% to 66.8%,showing a poor aggregate stability. Ari-Sandic Primosols have the highest PAD.
>0.25mm的水稳性团聚体变动在23.8%～45.4%,团聚体破坏率(PAD)为52.4%～66.8%,团聚体组成和特征有利于抵抗土壤风蚀,但稳定性差,灌溉后易于分散、沉实板结、通透性差。
8.Though the antibody activitiy of McAb1A 1 PAD DNR was significantly decreased, no significant decrease was observed in those of McAb1A 1 CADNR and McAb1A 1 PAD DNR.
间接法制备的 Mc Ab1A1 - PAD- DNR偶合物克分子比为 1∶ 437,保持了较好的抗体活性 ,药物活性保留 91.6 %。
9.Among the PVL-diagnosed lower limbs which PAD took 35% of the total number, 27.5% were found to have ABI≤ 1.0 and 22.5% with ABI ≤0.9. 32.5% were diagnosed PAD by both CDU and PVL.
PVL诊断有PAD的肢体占35%。 其中ABI≤1.0的肢体占27.5%,ABI≤0.9的肢体占22.5%。
10.Taking CDU diagnostic standard as definition, the related diagnostic criterions of PAD were assessed by the two methods of ankle - brachial index (ABI) and PVL.
以彩超诊断PAD为标准,评价踝肱指数(ABI)及PVL诊断PAD的相关诊断指标。
